Affymax (OTCPK:AFFY) - Stock Price, News & Analysis

AFFY Stock Overview

Does not have significant operations. More details

AFFY fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($60K)

High level of non-cash earnings

Shares are highly illiquid

Affymax, Inc. Competitors

Histogen

OTCPK:HSTO.Q

US$85.4k

Innovation Pharmaceuticals

OTCPK:IPIX

US$264.4k

Allena Pharmaceuticals

OTCPK:ALNA.Q

US$109.9k

Vaxxinity

OTCPK:VAXX

US$12.7k

Price History & Performance

Summary of all time highs, changes and price drops for Affymax
Historical stock prices
Current Share Price	US$0.0008
52 Week High	US$0.041
52 Week Low	US$0.0006
Beta	0
11 Month Change	0%
3 Month Change	14.29%
1 Year Change	n/a
33 Year Change	-84.31%
5 Year Change	-94.29%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	AFFY	US Biotechs	US Market
7D	0%	2.4%	0.5%
1Y	n/a	15.6%	30.7%

Return vs Industry: Insufficient data to determine how AFFY performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how AFFY performed against the US Market.

Price Volatility

Is AFFY's price volatile compared to industry and market?
AFFY volatility
AFFY Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: AFFY's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine AFFY's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	n/a	Jon Couchman	n/a

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Affymax, Inc. Fundamentals Summary

How do Affymax's earnings and revenue compare to its market cap?
AFFY fundamental statistics
Market cap	US$59.59k
Earnings (TTM)	US$3.07m
Revenue (TTM)	US$42.00k

0.0x

P/E Ratio

0.0x

P/S Ratio

Is AFFY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AFFY income statement (TTM)
Revenue	US$42.00k
Cost of Revenue	-US$167.00k
Gross Profit	US$209.00k
Other Expenses	-US$2.86m
Earnings	US$3.07m

Last Reported Earnings

Jun 30, 2014

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AFFY perform over the long term?

See historical performance and comparison